Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Coherus Oncology Inc., 3 years.
Coherus Oncology Inc.
Director
TriSalus Life Sciences Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
TriSalus Life Sciences Inc. June 12, 2025100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 5, 2026 | Coherus Oncology Inc. | Grant or award | +30,000 | — | — |
| May 15, 2026 | TriSalus Life Sciences Inc. | Open-market purchase | +60,000 | $2.53 | $151,800 |
| May 14, 2026 | TriSalus Life Sciences Inc. | Grant or award | +37,602 | — | — |
| May 14, 2026 | TriSalus Life Sciences Inc. | Grant or award | +34,226 | — | — |
| May 23, 2025 | Coherus Oncology Inc. | Open-market sale | −99,988 | $0.74 | $73,991 |
| Dec 17, 2024 | TriSalus Life Sciences Inc. | Grant or award | +25,188 | $3.97 | $99,996 |
| Nov 22, 2024 | TriSalus Life Sciences Inc. | Open-market purchase | +5,000 | $4.55 | $22,750 |
| Nov 21, 2024 | TriSalus Life Sciences Inc. | Open-market purchase | +8,687 | $4.44 | $38,570 |
| Nov 20, 2024 | TriSalus Life Sciences Inc. | Open-market purchase | +2,040 | $4.16 | $8,486 |
| Feb 9, 2024 | Coherus Oncology Inc. | Gift | −99,988 | — | — |
| Feb 9, 2024 | Coherus Oncology Inc. | Gift | +99,988 | — | — |
| Feb 1, 2024 | Coherus Oncology Inc. | Option exercise | +14,997 | $1.67 | $25,045 |
| Feb 1, 2024 | Coherus Oncology Inc. | Option exercise | +44,991 | $1.67 | $75,135 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.